Commentary by Rosemary Adamson, PGY2, Deena Altman PGY-1 and Harold Horowitz, Professor of Medicine, Section of Infectious Diseases
Syphilis is back! You know the drill: an 80-something year old man presents with dementia and …
Commentary by Rosemary Adamson, PGY2, Deena Altman PGY-1 and Harold Horowitz, Professor of Medicine, Section of Infectious Diseases
Syphilis is back! You know the drill: an 80-something year old man presents with dementia and …
Commentary By: Marshall Fordyce, PGY-3
Now that the dust has settled in Texas and Virginia, let’s clarify the role of the human papilloma virus (HPV) vaccine in our clinics. An excellent article in last week’s JAMA by its Editor-In-Chief, Dr. Catherine DeAngelis, and Lawrence Gostin, …
In February of this year the New York City Department of Health released a new policy paper indicating that they will no longer use the PPD as a screening tool for tuberculosis in their clinics.They have switched to the QuantiFERON-TB Gold, (QFT-G), a blood …
Welcome to Quick Thinking. A case is presented in short sections to a faculty expert who will comment on their approach to the patient as the case unfolds. These posts will focus on determining the initial differential diagnoses and diagnostic workups of complicated patient presentations.
Part 1 …
This week, olives from several different companies were found to contain Clostridium Botulinum. No cases of botulism have been reported to date, but this is an opportunity to review the pertinent clinical findings.
Botulism is caused by exposure to the botulinum neurotoxin in …
Commentary By: Danise Schiliro, PGY-3
Although intuitively we always worry about creating drug resistance when using antibiotics, there is a surprising lack of well done studies that show a clear causal effect of antibiotic use on the development of subsequent drug resistance. A …
Commentary By: Cara Litvin PGY-3
The CDC has issued a public health advisory regarding a large outbreak of Salmonella infections in 39 states since …
Commentary By: Marshall Fordyce, PGY-3
Extensively drug-resistant tuberculosis (XDR-TB) is as ominous as it sounds. As a second-year resident on the Chest service, you may have treated one or two patients with multi-drug resistant tuberculosis (MDR-TB), which …